![4-chloro-3-[[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methyl-1-oxobutyl]amino]-cyclopropyl-(S)-Benzenepropanoic acid](https://img.chemicalbook.com/CAS/20200401/GIF/1402936-61-1.gif)
LN-601632
4-chloro-3-[[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methyl-1-oxobutyl]amino]-cyclopropyl-(S)-Benzenepropanoic acid , 99% , 1402936-61-1
CAS NO.：1402936-61-1
Empirical Formula: C23H23Cl2F3NO3
Molecular Weight: 489.335
MDL number: MFCD32062664
Update time: 2023-04-23
PRODUCT Properties
| Boiling point: | 600.5±55.0 °C(Predicted) |
| Density | 1.416±0.06 g/cm3(Predicted) |
| solubility | DMSO : 125 mg/mL (255.97 mM; Need ultrasonic) |
| form | Solid |
| pka | 4.56±0.10(Predicted) |
| color | White to off-white |
Description and Uses
Runcaciguat is an orally active stimulator of soluble guanylate cyclase, and is used in the research of cardiovascular and renal diseases combined with selective partial adenosine A1 receptor agonists[1].
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264-P270-P301+P312-P330-P501 |